TMEABODY Trademark

Trademark Overview


On Wednesday, August 19, 2020, a trademark application was filed for TMEABODY with the United States Patent and Trademark Office. The USPTO has given the TMEABODY trademark a serial number of 90123489. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Shanghai IMMED Therapeutics Co., Ltd.. The TMEABODY trademark is filed in the Pharmaceutical Products category with the following description:

medicines for human purposes, namely, medicines for cancer diseases, cacinoma diseases, and malignant diseases; medicines for human purposes, namely, medicines for intestinal disorders, antiallergic medicines, medicines for dental purposes, medicinal herbs, medicines for the treatment of cardiovascular and cerebrovascular diseases; analgesics; pharmaceutical preparations, namely, pharmaceutical preparations for treating heart disease; pharmaceutical preparations for use in dermatology; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for treating chemical imbalances, chemical preparations for pharmaceutical or medical purposes, in particular, for the treatment of musculo-skeletal disorders, cancer diseases, cacinoma diseases, and malignant diseases; vaccines; drugs for medical purposes, namely, medicines for cancer diseases, cacinoma diseases, and malignant diseases, medicines for intestinal disorders, pharmaceutical preparations for treating heart disease; phar...
tmeabody

General Information


Serial Number90123489
Word MarkTMEABODY
Filing DateWednesday, August 19, 2020
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6734229
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements


Goods and Servicesmedicines for human purposes, namely, medicines for cancer diseases, cacinoma diseases, and malignant diseases; medicines for human purposes, namely, medicines for intestinal disorders, antiallergic medicines, medicines for dental purposes, medicinal herbs, medicines for the treatment of cardiovascular and cerebrovascular diseases; analgesics; pharmaceutical preparations, namely, pharmaceutical preparations for treating heart disease; pharmaceutical preparations for use in dermatology; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for treating chemical imbalances, chemical preparations for pharmaceutical or medical purposes, in particular, for the treatment of musculo-skeletal disorders, cancer diseases, cacinoma diseases, and malignant diseases; vaccines; drugs for medical purposes, namely, medicines for cancer diseases, cacinoma diseases, and malignant diseases, medicines for intestinal disorders, pharmaceutical preparations for treating heart disease; pharmaceutical capsules, namely, capsules sold empty for pharmaceuticals, drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer diseases, cacinoma diseases, and malignant diseases, mixed biological preparations for the prevention and treatment of infectious diseases; diagnostic preparations for medical purposes
Pseudo MarkTMEA BODY

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShanghai IMMED Therapeutics Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN

Party NameShanghai IMMED Therapeutics Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN

Party NameShanghai IMMED Therapeutics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN

Trademark Events


Event DateEvent Description
Wednesday, May 25, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 28, 2022CASE RETURNED TO EXAMINATION
Friday, January 28, 2022NOTICE OF ALLOWANCE CANCELLED
Friday, January 28, 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, January 27, 2022ASSIGNED TO PETITION STAFF
Friday, January 14, 2022TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 7, 2021EXAMINER'S AMENDMENT ENTERED
Friday, May 7, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 7, 2021EXAMINERS AMENDMENT E-MAILED
Friday, May 7, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 22, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 22, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 15, 2020ASSIGNED TO EXAMINER
Monday, September 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 22, 2020NEW APPLICATION ENTERED IN TRAM